The glucocorticoid receptor (GR) exerts numerous functions in the body and brain. In the brain, it has been implicated, amongst others, in feedback regulation of the hypothalamic-pituitary-adrenal axis, with potential deficits during aging and in depression. GRs are abundantly expressed in the hippocampus of rodent, except for the Ammon's horn (CA) 3 subregion. In rhesus monkey however, GR protein was largely absent from all hippocampal subregions, which prompted us to investigate its distribution in human hippocampus. After validation of antibody specificity, we investigated GRa protein distribution in the postmortem hippocampus of 26 human control subjects (1e98 years of age) and quantified changes with age and sex. In contrast to monkey, abundant GR-immunoreactivity was present in nuclei of almost all neurons of the hippocampal CA subfields and dentate gyrus (DG), although neurons of the CA3 subregion displayed lower levels of immunoreactivity. Colocalization with glial fibrillary acidic protein confirmed that GR was additionally expressed in approximately 50% of the astrocytes in the CA regions, with lower levels of colocalization (approximately 20%) in the DG. With increased age, GR expression remained stable in the CA regions in both sexes, whereas a significant negative correlation was found with age only in the DG of females. Thus, in contrast to the very low levels previously reported in monkey, GR protein is prominently expressed in human hippocampus, indicating that this region can form an important target for corticosteroid effects in human.
Introduction
Glucocorticoid hormones (GCs) are important mediators of the stress response in mammals, including humans. Exposure to a stressor triggers activation of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus (PVN) of the hypothalamus, which eventually induces GC release from the adrenal gland. GCs are highly lipophylic transcription factors that exert numerous effects on metabolism, inflammation, and cognition (de Kloet et al., 2005) . When in the circulation, GCs exert negative feedback inhibition on the same regions that triggered their initial release (i.e., the hypothalamus and pituitary), and they also influence behavioral adaptation. These latter effects are generally thought to be mediated, at least partly, through the low affinity glucocorticoid receptor (GR) that is abundantly expressed in the hippocampus of rodents (Reul and de Kloet, 1985) . The hippocampal formation is a key limbic region that participates in spatial navigation and the modulation of cognition, mood, and behavior (de Kloet et al., 2005) . Based on the presence of GR and the results from various pharmacological studies it has been postulated that the hippocampus is an area in which GCs act to modulate behavior and hypothalamo-pituitary-adrenal (HPA) axis activity (Jacobson and Sapolsky, 1991; Juruena et al., 2006; Sapolsky et al., 1984) .
The GR is a member of the nuclear hormone receptor superfamily of ligand-activated transcription factors. After ligand binding, the hormone receptor complex translocates from the cytoplasm to the nucleus where it influences gene transcription.
In rodents, GR is the dominant receptor that mediates effects of stress levels of GCs, and helps to maintain GC levels within specific limits (Erdmann et al., 2008; Kretz et al., 1999) . Aberrant GR expression has been implicated in stress resistance, anxiety, and depression (Alt et al., 2010; de Kloet et al., 2005; Ridder et al., 2005; Wang et al., 2012; Wei et al., 2007) . In humans, there is a considerably diversity of GR transcripts and isoforms (Sinclair et al. 2011) , which includes 13 exon 1 messenger RNA variants and 8 N-terminal variants, which arise from the predominant GR isoform, GRa, that differ in size from 94 to 54 kDa based on the location of their translation start site.
The regional distribution of the GR protein in the hippocampus has been studied before in various species. In rodents, GR expression is ubiquitous throughout the brain and enriched in key regions of the HPA axis and the hippocampus, and GR is abundantly expressed in the CA pyramidal cell layer and in the granule cell layer of the dentate gyrus (DG), with generally lower levels in the CA3 subregion Sarabdjitsingh et al., 2010) .
In contrast to this well-established distribution in rodent brain, distribution of GR protein in the primate hippocampus is poorly studied. To date, there are no detailed studies of regional protein expression of the GR in the human hippocampus. In rhesus monkey, a general absence of GR was reported in the main neuronal layers of the hippocampal formation, and astroglia did express GR (Sanchez et al., 2000) . Because this suggested a species difference in GR expression, we set out to study GR protein distribution in the human hippocampus and hypothalamus.
To validate our antibody and address the influence of postmortem delay on GR expression, we studied a series of postmortem rat brains, performed antigen preadsorption and Western blot, and studied GR coexpression in CRH-containing parvocellular neurons of the human hypothalamic PVN, an important nucleus for GR-mediated feedback inhibition, that also expresses vasopressin, and is involved in HPA feedback inhibition, and as such, is expected to at least express significant levels of GR protein (Erkut et al., 1998; Han et al., 2005; Kretz et al., 1999; Lucassen et al., 1994; Uht et al., 1988; Wang et al., 2008) . We next questioned whether GR expression in the human hippocampus is comparable with the distribution in the rodent or primate hippocampus. Third, considering the numerous reports on changes with age (Bao and Swaab, 2007; Bizon et al., 2001; Hassan et al., 1999; Mizoguchi et al., 2009; Murphy et al., 2002; Perlman et al., 2007; Raadsheer et al., 1993; Sinclair et al., 2011; van Eekelen et al., 1992) , we investigated whether age-and sex-related changes in GR protein occur in a cohort of 26 control subjects ranging from 1 to 98 years of age.
Methods

Human brain tissue
Postmortem human brain tissue used in this study was obtained from the Netherlands Brain Bank (NBB) and written permission was obtained from the patients or the next of kin for all brain autopsies and for the use of the tissues and clinical data for research purposes. Twenty-six subjects were studied, 12 male and 14 female, ranging in age from 1 to 98 years. Clinicopathological details on disease condition, cause of death, pH of cerebrospinal fluid, and postmortem delay (PMD) are given in Table 1 .
The hippocampus proper was dissected at autopsy, fixed in formalin for 1e2 months, dehydrated, embedded in paraffin, and serially sectioned at 8 mm. Midlevel sections of each subject were used for immunohistochemistry for GR. To study whether GRimmunoreactivity (ir) is distributed in a homogenous way along the septotemporal axis, 3 groups of 4 additional patients were selected at a rostral, middle, and caudal level of the hippocampus and compared (see Supplementary Fig. 1 and Table 1 ). To further investigate the distribution of GR in astroglia, a series of sections from 4 additional confirmed control subjects were used for immunohistochemical double staining of GR and glial fibrillary acidic protein (GFAP). For the analysis of GR and its coexpression in CRH neurons, additional hypothalamic tissue (6 mm) was used of 2 confirmed control cases obtained from the NBB (Table 1) . Two freshly frozen cortices and 2 frozen hippocampi were further obtained from the Department Neuropathology of the Academic Medical Center (University of Amsterdam) and used for Western blot analysis to confirm specificity of the GR antibody (Table 1) . Extensive clinicopathological investigation at the Department of Neuropathology had confirmed their control status.
Methodological optimization; influence of PMD on rat GR immunohistochemistry
For human brain, possible effects of PMD need to be taken into account, not only with respect to total GR expression levels per se that might be subject to protein breakdown, but also regarding differences in the intracellular distribution of nuclear receptors between cytoplasm and nucleus, as was for example, found under conditions of glucocorticoid absence or after artificial PMDs (Fodor et al., 2002; Nishi and Kawata, 2007; Visser et al., 1996) . We therefore studied in 3-month-old Sprague-Dawley rats the effect of different postmortem times on GR expression in 6 brains that were kept at RT for 0, 3, and 6 hours after death before dissection of the brain and immersion fixation in formalin for 7 days. The PMD rat brains were then processed at the NBB and embedded in paraffin using the exact same embedding protocol as used for the human PMD brain tissue in this study.
Eight micrometer thick paraffin sections were cut and a wellcharacterized rat GR antibody was used to study GR in these PMD rat studies. Mounted rat hippocampal sections were deparaffinized, rehydrated, and placed in a conventional microwave oven (Miele) in citrate buffer (0.01 M, pH 9.0) for 20 minutes for antigen retrieval. After cooling down for 30 minutes, sections were incubated in 0.3% H 2 O 2 in methanol for 30 minutes to block endogeneous peroxidase activity. After washing in Tris buffered saline (TBS; 0.05 M Tris and 0.15 M NaCl, pH 7.6), the rat hippocampal sections were incubated in the primary GR antiserum for 1 hour at room temperature (RT), followed by an overnight incubation at 4 C. Antiserum was diluted in Supermix (0.05 M TBS buffer containing 0.5% Triton-X and 0.25% gelatin, pH 7.6) at a concentration of 1:2000. After rinsing in TBS, sections were incubated in a 1:200 dilution of biotinylated goat anti-rabbit IgG (Vector Laboratories) in Supermix for 1 hour at RT. After rinsing in TBS, sections were incubated in a 1:800 dilution of streptavidin-biotin-peroxidase complex (Vectastain ABC Elite kit; Vector Laboratories) in Supermix for 1 hour at RT. After rinsing in TBS and incubation in 3,3-diaminobenzidine (DAB)-ammonium nickel solution (0.5 mg/mL DAB, 0.01% H 2 O 2 , 2.33 mg/mL nickel ammonium sulfate in TBS) at RT for 10 minutes, the sections were rinsed in TBS, dehydrated, and coverslipped with Entallan (Merck).
Human GR antibody validation
Considering the discrepancy between the GR pattern in rat and primate, we choose to use the same antibody as had been used before in the study on GR in the rhesus monkey (Sanchez et al., 2000) (i.e., the affinity purified rabbit polyclonal GR antiserum; E-20, human GR, Santa Cruz Biotechnologies), that was directed against the N-terminus of the classic human GRa protein and has been used and validated in various previous reports (Lu et al., 2006; Vancurova et al., 2001) . Preadsorption, omission of the first antibody and Western blot on human brain tissue was performed to confirm its specificity. Two pieces of control cortex and 2 control hippocampi from 4 different patients were homogenized in lysis buffer containing 10 mM Tris (pH 8.0), 150 mM NaCl, 10% glycerol, 1% Nonidet P-40 (NP-40), 0.4 mg/mL Na-orthevanadate, 5 mM ethylenediaminetetraacetic acid (EDTA) (pH 8.0), 5 mM NaF, and protease inhibitors (cocktail tablets, Roche Diagnostics, Mannheim, Germany). Protein content was determined using the bicinchoninic acid method. For electrophoresis, equal amount of proteins (50 ug per lane) were separated by sodium dodecylsulfate-polyacrylamide gel electrophoretic analysis (10% acrylamide). Separated proteins were transferred to nitrocellulose paper by electroblotting for 1 hour and 30 minutes (BioRad, Transblot SD, Hercules, CA, USA). After blocking for 1 hour in 20 mM Tris, 150 mM NaCl, 1% Tween, pH 7.5 (TBST )/5% nonfat dry milk, blots were incubated overnight at 4 C with the GR antibody (1:1000). After several washes in TBST, the membranes were incubated in TBST/5% nonfat dry milk, containing horseradish peroxidase (HRP)-labeled goat anti-rabbit (Dako; 1:2500) for 1 hour at RT. Ir was visualized using Lumi-light PLUS Western blotting substrate (Roche Diagnostics) and digitized using a Luminescent Image Analyzer (LAS-3000, Fuji Film).
Immunohistochemistry for human GR
Mounted hippocampal sections were deparaffinized in xylene, rehydrated in graded ethanol, and placed in a glass jar with citrate buffer (0.01 M, pH 6.0) that was positioned inside a kitchen steamer device (Braun FS20). To unmask hidden antigens because of formalin fixation, this steamer was filled with distilled water and sections were heated at full power for 1 hour. After cooling down for another 30 minutes, the sections were incubated in 0.3% H 2 O 2 in methanol for 30 minutes to block endogenous peroxidase activity.
After washing in TBS, the primary antiserum was added to the sections for 1 hour at RT, followed by an overnight incubation at 4 C. Antiserum was diluted in supermix at a concentration of 1:1000. After retrieving the primary antibody and rinsing in TBS, sections were incubated in a 1:200 dilution of biotinylated goat anti-rabbit IgG in Supermix for 1 hour at RT. Signal was further amplified by a second incubation with the retrieved primary antibody and goat anti-rabbit IgG both for 1 hour at RT. After rinsing in TBS, sections were incubated in a 1:800 dilution of streptavidinbiotin-peroxidase complex (ABC Elite, Vector Laboratories) in Supermix for 1 hour at RT. After washing in TBS, sections were incubated in Tyramide in TBS (1:750 Tyramide in TBS, 0.01% H 2 O 2 ; a generous gift from Dr I. Huitinga, NBB Amsterdam) for 30 minutes at RT. After washing in TBS, sections were again incubated in 1:800 dilution of streptavidin-peroxidase complex in Supermix for 45 minutes at RT. The sections were then rinsed in TBS and incubated in DAB-nickel solution at RT for 40 minutes, rinsed in TBS, dehydrated, cleared in xylene, and coverslipped.
Additional specificity tests consisted of: (1) omission of the first antibody; and (2) preadsorption of the primary antisera with the corresponding GR peptide antigen (sc-1003 P, Santa Cruz). Preadsorption of the first antiserum was at 1:100 according to standard procedures. Briefly, after coating nitrocellulose (NC) paper (3MM; Whatman) in 2% gelatin solution at 40 C in a water bath for 1 hour, the NC paper was dried overnight. One mL of a peptide dilution series made in 10% glycerol (100%) plus 10% dimethylformamide (100%) plus 2.5% Nonidet (100%) medium was spotted on gelatin-coated NC that was left to dry for 1 hour. Whatman 3MM paper was then incubated in freshly made buffered 4% paraformaldehyde (pH 7.6) for 5 minutes and dried. The paraformaldehyde-containing filter paper was used to fix the spotted proteins on the NC by placing it in a press block (parafilm plus NC plus filter paper containing fixative plus parafilm) overnight. After washing the NC in H 2 O, 0.05 M Tris/HCl (3.03 g Tris plus 500 mL aqua dest, pH 7.6), and supermix, the NC sheet was then incubated in the antibody solution for 4 hours (RT). The antibody solution was re-collected and then used as first antibody for immunocytochemistry.
Immunofluorescent double staining for GR and CRH
Because glucocorticoid feedback of the HPA axis is known to occur to a large extent at the level of the parvocellular CRH neurons located in the hypothalamic PVN (Kretz et al., 1999) , these neurons are expected to at least express significant amounts of GR (Han et al., 2005) and a double immunofluorescent staining protocol for CRH and GR was therefore developed. Double staining for GR and CRH was performed on sections located approximately in the middle of the PVN region of 2 established control subjects of 46 and 49 years of age; patient numbers 96-411 and 98-200 (Table 1) . The sections were mounted on Super-Frost/Plus (Menzel) slides and airdried. After deparaffinization and rehydration in graded ethanols, the hypothalamic sections, similar to the hippocampal GR protocol, were placed in citrate buffer (0.01 M, pH 6.0) and heated in the steamer for 1 hour. After cooling down for another 30 minutes, sections were coincubated with antibodies against GR (E-20) and CRH (PFU-83), diluted in Supermix at 1:250 and 1:5000, respectively, for 1 hour at RT and overnight at 4 C. The CRH (PFU-83) antibody is directed against the extreme C-terminal part (amino acids 38e39) of corticotropin-releasing factor (CRF), has been characterized extensively before (de Goeij et al., 1992; van Oers et al., 1989) and has been used before on human hypothalamic sections as well (Erkut et al., 1998; Raadsheer et al., 1993) . After washing in TBS, sections were incubated with the fluorescent secondary antibody Alexa 488 anti-rat (1:400) and Alexa 594 antirabbit (1:400) for 4 hours at RT before rinsing in TBS. Sections were coverslipped with glycerin and viewed under a regular fluorescence microscope (model E800; Nikon, Tokyo, Japan) and photographed on a confocal laser scanning microscope (model LSM510; Carl Zeiss, Oberkochen, Germany). For identifying the parvocellular and the magnocellular neurons of the PVN in the hypothalamus, the human hypothalamus has no specific subregions where CRH neurons are concentrated, as in rat (Kiss et al., 1991) , but because CRH-positive parvocelllular neurons are distributed throughout the human PVN (Raadsheer et al., 1993) we used, aside from CRH ir, morphologic and size criteria to distinguish magnocellular from parvocellular neurons.
2.6. Double immunocytochemical staining for human GR and the astrocyte marker GFAP Double staining for GR and GFAP protein was performed at light microscopical level in order to investigate the presence and subregional hippocampal distribution of the GR in astrocytes. After immunocytochemical detection of GR using DAB with ammoniumnickel amplification, yielding a black precipitate, the sections were subsequently incubated with an antibody directed against GFAP (pan-GFAP; Dako) in Supermix at concentration of 1:1000 for 1 hour at RT and then overnight at 4 C. After rinsing in TBS, sections were incubated in biotinylated goat anti rabbit IgG (1:200) in Supermix for 1 hour at RT, washed in TBS before signal amplification with ABC at a 1:800 dilution in Supermix for 1 hour at RT. Sections were developed in DAB solution at RT for 10 minutes, yielding a brown precipitate, rinsed in TBS, dehydrated, cleared in xylene, and coverslipped.
For quantification, 3 microscopic fields corresponding to a 40Â magnification were placed over the subregion of interest and the number of astrocytes counted and the percentage of cells coexpressing GR and GFAP determined.
Image analysis and quantification
Immunocytochemical signal was quantified using image analysis tools described before in detail (Ishunina et al., 2003; Ishunina et al., 2005) . Measurements were performed using an IBAS-KAT image analysis system (Kontron KAT-based system). The image analysis system was connected to a SONY XC-77CE black and white CCD camera mounted on a Zeiss microscope. Sampling and area selection of the hippocampus were performed as follows; in each hippocampal section to be analyzed, an area including the CA and DG subregion (using the 20Â objective of the microscope) was loaded into the IBAS and displayed on the image analysis monitor. The position of the section under the microscope was stored using the xey coordinates of the scanning stage. In this image, the contour of the CA1, CA3, or DG was outlined manually. To determine the amount of DAB-Ni precipitate corresponding to GR ir, pictures were first collected of the hippocampus taken at magnification 20Â. The contours of the different hippocampal subregions are then outlined manually, based on the atlas of the human hippocampus of Duvernoy. Within each contour, a thresholding procedure is used to select only those pixels that contain DAB-Nickel precipitate, corresponding to GR ir. The threshold of the mask is set by the observer at minimal 3.5Â background level in such a way that it covers only the immunopositive pixels within the outlined area of the contour. Of the pixels within this mask, the computer then determines optical density (OD) and the percentage of surface area covered by GR-ir signal (P SA ) for each subregion, per patient which was then correlated with age and sex. The thresholding procedure assures that background or other surface areas not covered by GR signal are excluded from the quantification. This procedure has also been applied for comparable analyses before (Ishunina et al., 2007) . Because the data are presented as densities, they reflect changes in total amount of GR protein to the extent that the volumes of these regions do not change in volume. Statistical analysis was conducted with SPSS (SPSS statistical software version 20). The differences between the groups were statistically evaluated using analysis of variance. Spearman correlation was used to analyze the correlation of GR-ir with age. Values of p < 0.05 were considered significant.
Results
Methodological optimization; validation of human GR antibody specificity
Western blot with human anti-GR antiserum (E-20) performed on samples from freshly-frozen biopsy human cortical tissue revealed a single band corresponding with the expected height of the GRa (Fig. 1A) (Han et al., 2005; Sinclair et al., 2011) .
No GR-ir was observed in any of the human hypothalamic or hippocampal sections after omission of the primary antiserum (not shown), though preadsorption of the primary antisera with the corresponding peptide antigen used to generate the antibody (sc-1003 P; Santa Cruz), completely abolished all GR-ir in the human hippocampus (Fig. 1B) indicating specificity of the E-20 antibody.
Influence of PMD on GR levels
In paraffin sections of the rat brain tissue that was rapidly immersion fixed after a PMD of 0 hours, prominent ir for GR was found in almost all neuronal nuclei of the hippocampus (Fig. 2) .
Consistent with its known distribution in rodent , abundant GR-ir was present in the neuronal layers of the CA1 and DG and in hilar cells, but not in some neurons of the CA3 subregion (arrowhead in Fig. 2) , that was largely devoid of any GR staining. Although GR-ir was present in small astrocytes, its distribution in neurons was largely nuclear throughout the main subregions and no GR-ir was observed in the cytoplasm. This pattern did not change when tissues were fixed after PMDs of 3 and 6 hours respectively (Fig. 2) . Nuclear GR-ir after such PMDs remained present at similar densities throughout the DG and CA neuronal layers. There were no obvious differences in nuclear staining intensity when compared with the PMD 0-hour time point, nor did any cytoplasmic staining appear with increasing PMDs (3 and 6 hours) in either of the subregions, indicating a pronounced stability of GR protein with increasing PMDs, that was relevant for the present human cohort.
GR immunohistochemistry in human hypothalamus
To further confirm antibody specificity, we assessed whether parvocellular CRH neurons in the human hypothalamic PVN coexpress GR. Double immunofluorescent staining for GR and CRH was performed on hypothalamic sections containing the PVN region of established cases.
In the human hypothalamic sections, nuclear GR expression was seen throughout the main hypothalamic nuclei, such as the periventricular nucleus of the ventral zone, the diagonal band of Broca, the nucleus basalis of Meynert, and parts of the bed nucleus of the stria terminalis. Abundant GR expression was observed in neurons of the supraoptic nucleus and PVN (Fig. 3) . In the supraoptic nucleus, GR-ir was generally found in neuronal nuclei. In the PVN, GR-ir was particularly detected in small neurons that coexpressed CRH ir (Fig. 4) . Taken together with the data from the Western blot and the preadsorption test, this confirmed specificity of the E-20 antibody.
GR immunohistochemistry in human hippocampus
In the human hippocampus, GR-ir was observed as a prominent pattern of expression throughout the pyramidal and granule layers (Fig. 2) . Strong nuclear staining was present in DG and CA neurons, and in the CA3 subregion, although the latter region displayed a more sparse distribution and occasionally neurons without GR-ir nuclei were present here as well, similar to the distribution in rodent brain. In the DG, intense nuclear GR-ir was present in almost all granule cells that were densely packed together, whereas the CA1 neurons were more dispersed. This pattern was confirmed by quantification of the optical density and surface area covered by GR-ir. Thus, when comparing the different hippocampal subregions for GR-ir by using analysis of variance, a significant difference was found in OD of the GR signal between CA3 and DG (p < 0.01) and between CA1 and DG (p < 0.01), but not between CA1 and CA3 (p ¼ 0.253). For P SA of GR-ir, significant differences were found between CA1 and CA3 (p < 0.01); CA1 and DG (p < 0.01) and between CA3 and DG (p < 0.01) corresponding to different package densities. Because the present quantification was performed at the midlevel, we specifically compared different additional anatomic levels (4 patients at a more rostral and 4 at a more caudal level) but did not find major differences from the values reported when sampled at the hippocampal midlevel (see Supplementary Fig. 1 and Supplementary Table 1) .
Colocalization with the astrocyte marker GFAP confirmed that GR was not only confined to the neuronal population, but also expressed in a subset of astroglia (Fig. 2) . Quantification of the percentage of double staining in CA1, CA3, hilus, and cortex of human brain sections revealed that approximately 50% of the astrocytes in these regions express GR, a percentage that is lower in the DG where approximately 20% of the GFAP positive astrocytes coexpress GR. 
Correlations of GR expression with age and/or sex
Testing our cohort for correlations between GR expression with PMD or age revealed that the groups of male and female did not differ significantly in these parameters (age, p ¼ 0.77; PMD, p ¼ 0.35). In addition, correlating (1) OD and (2) percentage of surface area covered by GR-ir signal (P SA ) with the PMDs of all subjects, revealed no significant correlation for these parameters in either of the subregions (OD: CA1, p ¼ 0.413; CA3, p ¼ 0.251; DG, p ¼ 0.330; P SA : CA1, p ¼ 0.130; CA3, p ¼ 0.584; DG, p ¼ 0.104), confirming our rat data also in human brain: that PMD does not affect GR-ir.
No significant correlation was found for between age and GR-ir in all subjects in either subregion (OD: CA1, p ¼ 0.348; CA3, p ¼ 0.962; DG, p ¼ 0.171; P SA : CA1, p ¼ 0.069; CA3, p ¼ 0.081; DG, p ¼ 0.086; see Fig. 5 ). Also, no significant change correlation was found when comparing examining the male group alone only; OD: CA1, p ¼ 0.828; CA3, p ¼ 0.794; DG, p ¼ 0.777; P SA : CA1, p ¼ 0.662; CA3, p ¼ 0.163; DG, p ¼ 0.427). In the female group however, P SA of GR-ir was found to decline significantly with age in the DG but not in one of the other subregions, OD was not affected in the DG nor in the CA subregions; (OD: CA1, p ¼ 0.171; CA3, p ¼ 0.970; DG, p ¼ 0.076; P SA : CA1, p ¼ 0.055; CA3, p ¼ 0.366; DG, p ¼ 0.029.
Discussion
We demonstrate that GR protein is abundantly expressed throughout the main neuronal subregions of the DG and CA of the human hippocampus, and in approximately 50% of the astrocytes. This distribution pattern is comparable with the rodent hippocampus and differs from that of the rhesus monkey, where very low levels of GR were reported before (Sanchez et al., 2000) . PMD was shown not to affect these data, neither in a correlative study in the human hippocampus, nor in an experimental study in the rat.
We further validated our antibody on Western blot, and the slightly lower molecular weight found with the GRa antibody E-20 is consistent with a previous molecular study confirming that, in addition to the archetypal full-length 94 kDa receptor, multiple true GRa variants exist in vivo. Irrespective of possible posttranslational modification, the predominant isoform in human brain tissue was the 67 kDa isoform, regardless of the anti-GRa antibody used (Sinclair et al., 2011) . Also, this variant follows the same developmental pattern as the full length GRa-A form (Sinclair et al., 2011) . Second, preabsorption tests resulted in the expected absence of staining. Finally, high GR expression was expected and indeed selectively observed in the CRH-producing, parvocellular, but not magnocellular, neurons in the hypothalamic PVN. This strongly supports that the antibody indeed identifies GR in the human hippocampus.
Our new protein distribution data are consistent with previous papers demonstrating prominent expression of mRNA for the GR in the human hippocampus (Alt et al., 2010; DeRijk et al., 2003; Klok et al., 2011a; Lopez et al., 1998; McGowan et al., 2009; Turner and Muller, 2005; Watzka et al., 2000; Webster et al., 2002) . Also with in situ hybridization, abundant GR mRNA was found in the human DG and CA subfields (Lopez et al., 1998; Noorlander et al., 2006; Seckl et al., 1991 Seckl et al., , 1993 Wetzel et al., 1995) .
Clear differences have been reported in various structural, metabolic, or functional parameters over the septotemporal or horizontal axis of the hippocampus, for example, using highresolution positron emission tomography/magnetic resonance imaging (Cho et al., 2011) , magnetic resonance spectroscopy (King et al., 2008) , N-methyl-D-aspartate/a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (NMDA/AMPA) receptor distribution (Pandis et al., 2006) , or electrophysiological readouts (Maggio and Segal, 2009) , and in terms of disease vulnerability or synaptic connectivity, the hippocampus also shows anatomic differences (Ta et al., 2012; Thom et al., 2012; Harrison and Eastwood, 2001) . In view of these gradients along the septotemporal axis, we also studied GR levels at more rostral and more caudal levels in an additional set of patients, but did not find major differences compared with our measurements performed at the midlevel (see Supplementary data). This indicates that GR protein is distributed in a homogenous way along the entire septotemporal axis of the human hippocampus.
Another possible confound could be atrophy of the hippocampus that might occur with age. However, in a previous study, such changes were reported to occur mostly in the head and tail of the hippocampus (Pruessner et al., 2001 ) and because midlevels were studied here, atrophy of the hippocampus should thus not pose a major problem for our current results. However, the present data are presented as densities and thus reflect changes in the total amount of the (GR) protein in the various brain regions only to the extent that the volumes of these regions do not change in volume during aging. Considering the present abundant distribution pattern, a largely absent expression of GR protein, as was found in rhesus monkey (Sanchez et al., 2000) , would have been very surprising. Moreover, a variety of experimental studies in humans have shown potent effects on hippocampus-and GR-dependent cognitive functions, confirming the high sensitivity of the hippocampus to stress and GCs (Cornelisse et al., 2011; Henckens et al., 2009; Khalili-Mahani et al., 2010; Kumsta et al., 2010; Lovallo et al., 2010; Lupien et al., 2007; Zobel et al., 2008) .
Although the human hippocampus is clearly responsive to GCs in functional terms, these effects are not necessarily mediated through GRa alone. Various splice variants of GR not studied here, might contribute as well (Alt et al., 2010; Kumsta et al., 2010; Sinclair et al., 2011; Sinclair et al., 2012; Webster et al., 2002) . The rodent hippocampus is further enriched not only with GR but also with high-affinity mineralocorticoid receptors (MR) that are occupied already at low levels of the stress hormone. Recent studies have implicated MR in rapid, nongenomic effects on rat hippocampal neurons (de Kloet et al., 2008; Joels and Baram, 2009; , in structural plasticity (Gass et al., 2000) , but also in aspects of human HPA axis regulation, mood, and depression (DeRijk et al., 2011; Klok et al., 2011a; Wang et al., 2008; Wickert et al., 2000; Xing et al., 2004) . So far, MR mRNA and protein have been identified in human brain (Klok et al., 2011a (Klok et al., , 2011b Qi et al., 2012; Xing et al., 2004) , and also high MR mRNA levels have been described in the hippocampal DG and CA2eCA3 of marmoset (Johnson et al., 1996) , squirrel (Patel et al., 2000) , rhesus monkey (Meyer et al., 1998 (Meyer et al., , 2001 Sanchez et al., 2000) , and in humans (Seckl et al., 1991; Wetzel et al., 1995) . For MR and GR, the cDNA sequence is conserved among New World monkeys and homology with human MR and GR is high (Brandon et al., 1991; Patel et al., 2000) . Although beyond the scope of the present study, the ratio between GR and MR might be important for age-related hippocampal changes and/or vulnerability for disease, and will be important to consider in future studies (de Kloet et al., 2005; Qi et al., 2012) .
In previous reports, changes in HPA parameters or stress responsivity have been associated with altered GR protein expression in the hippocampus (e.g., during age) (Herman and Spencer, 1998; Mizoguchi et al., 2009; Patel et al., 2008) . For instance, in Lewis rats, which exhibit HPA hypoactivity, high levels of GR expression are present, whereas in the Fisher rat, the opposite is found. Also, downregulation of the GR by stress has been observed in monkeys (Meyer et al., 2001; Pryce, 2008) . In human aging, increases in cortisol levels and other HPA parameters have been reported (Bao and Swaab, 2007; Conrad and Bimonte-Nelson, 2010; Lupien et al., 1998; Raadsheer et al., 1993 Raadsheer et al., , 1994 Raadsheer et al., , 1995 Swaab et al., 2005) . Yet, the present data suggest that at least in the human hippocampus, GR levels are generally not altered with age, except for the age-associated decline in the DG of females. A general stability of hippocampal GR expression during age was also reported earlier at the mRNA level although increases were found in the prefrontal cortex (Perlman et al., 2007) . In addition, differential patterns have been observed over the life span for the different GRa variants (Sinclair et al. 2010) . Additional postmortem studies on GR mRNA expression in patients diagnosed with schizophrenia or Fig 5. Quantification of hippocampal glucocorticoid receptor (GR)-immunoreactivity (ir) expressed as: total surface areas covered by the GR-ir (P SA , left series) and: averaged optical density (OD, right series) and the correlations of both these GR-ir parameters with age, plotted for CA1, CA3, and dentate gyrus (DG).
major depressive disorder, all of which were accompanied by hypercortisolemia, also failed to show a reduction in hippocampal GR mRNA level.
Regarding the present reduction in GR protein expression in the female DG with age, clear sex differences in cortisol level and CRH expression have been reported before (Bao and Swaab 2007; Erkut et al., 2004; Heuser et al., 1994; Wang et al., 2012) . Androgens selectively modulate GR, but not MR (Kerr et al., 1996) and older women display stronger increases in salivary free cortisol than older men (Bao et al., 2008; Seeman et al., 2001) . In postmortem brain, increased levels of GR mRNA were reported in the cortex of females compared with males, but no sex differences were reported in the hippocampus. This was however measured in hippocampal homogenates and hippocampal subregions were not distinguished . Clearly, sex differences need to be taken into account when investigating levels of hormones and their receptors, even with rare human material.
In addition to the current GR expression in neuronal nuclei, GR was expressed in approximately 50% of the astroglial cells in the human CA, hilus, and cortex, with lower levels in the DG. In previous studies in rats, glia cells were shown to express both GR and MR, and to be capable of responding to steroid exposure (Bohn et al., 1991; Cintra et al., 1994) . We show that also in humans, GR is expressed in a considerable proportion of astroglia which can hence form a relevant substrate for mediating glucocorticoid responsivity. Functionally, GCs might impair the ability of astrocytes to aid neurons (e.g., by impairing their ability to buffer glutamate from the synapse; Virgin et al., 1991) . Glial deficits have been reported in the prefrontal cortex (PFC) after stress, and stress also affected astrocyte number in tree shrews (Czeh et al., 2006; Stockmeier et al., 2004) . Possibly, such glia changes could contribute to hippocampal volume reductions as well (Czeh and Lucassen, 2007) .
The low GR expression in the hippocampus of rhesus monkeys (Sanchez et al., 2000) was in contrast to the strong GR expression in the hippocampus of rodents (Fuxe et al., 1985; Morimoto et al., 1996; Sarabdjitsingh et al., 2009; Van Eekelen et al., 1988) and other mammals (Pryce, 2008) , like guinea pig, pig (Weaver et al., 2000) , marmoset (Pryce et al., 2005) , squirrel monkey (Patel et al., 2000) , and tree shrews (Meyer et al., 1998 (Meyer et al., , 2001 . Because much research on stress or glucocorticoid actions on the brain is performed in rodents, the low GR expression levels in this particular primate (Sanchez et al., 2000) suggested at the time that if similar low densities of GR were present also in the human hippocampus, this might have considerable relevance for the extrapolation of findings on GCs in rodents to similar actions and stress-related pathologies in humans.
Although beyond the scope of the present report, it remains unclear why the hippocampus of the rhesus monkey would contain low GR levels because several studies in other nonrodent or primate species have shown prominent expression of GR in the hippocampus (Johnson et al., 1996; Meyer et al., 1998; Patel et al., 2000 Patel et al., , 2008 Pryce et al., 2005) , suggesting that the rhesus monkey is indeed an exception in this respect. One explanation could be that this pattern is unique and that in this particular primate, neocortical and hypothalamic areas, that did express high GR levels (Sanchez et al., 2000) , might be more important glucocorticoid targets than the hippocampus. Another possibility is that similar to other monkey studies, previous (early life) stress influenced GR levels in this particular study (Arabadzisz et al., 2010; Meyer et al., 2001; Patel et al., 2008) . In humans, adverse early life events such as childhood abuse have been shown to affect human GR expression and HPA function and to form important risk factors for HPA regulation, structural alterations, and depression during adult life (McGowan et al., 2009; Oberlander et al., 2008; Wang et al., 2012 ).
In summary, high level of GRa protein are present in human hippocampal neurons and glia throughout the DG and CA subfields. This indicates that the human hippocampus can be sensitive to GC exposure, consistent with a variety of effects of GC or stress exposure on human hippocampal cognitive functions.
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